Wells Fargo’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$535K Buy
258,248
+181,082
+235% +$375K ﹤0.01% 3737
2025
Q1
$170K Buy
77,166
+2,403
+3% +$5.29K ﹤0.01% 4372
2024
Q4
$114K Buy
74,763
+13,568
+22% +$20.8K ﹤0.01% 4637
2024
Q3
$122K Buy
61,195
+593
+1% +$1.18K ﹤0.01% 4508
2024
Q2
$212K Buy
60,602
+19,238
+47% +$67.3K ﹤0.01% 4138
2024
Q1
$115K Buy
41,364
+4,012
+11% +$11.1K ﹤0.01% 4443
2023
Q4
$63.5K Buy
37,352
+6,843
+22% +$11.6K ﹤0.01% 4760
2023
Q3
$31.4K Sell
30,509
-21,775
-42% -$22.4K ﹤0.01% 5050
2023
Q2
$60.7K Buy
52,284
+21,430
+69% +$24.9K ﹤0.01% 5061
2023
Q1
$46.6K Buy
30,854
+20,877
+209% +$31.5K ﹤0.01% 4900
2022
Q4
$24.9K Sell
9,977
-3,772
-27% -$9.43K ﹤0.01% 4855
2022
Q3
$58K Sell
13,749
-32,089
-70% -$135K ﹤0.01% 4580
2022
Q2
$128K Sell
45,838
-55,249
-55% -$154K ﹤0.01% 4249
2022
Q1
$579K Sell
101,087
-3,025
-3% -$17.3K ﹤0.01% 4049
2021
Q4
$951K Sell
104,112
-64,977
-38% -$594K ﹤0.01% 3897
2021
Q3
$1.81M Buy
169,089
+2,546
+2% +$27.2K ﹤0.01% 3564
2021
Q2
$2.59M Buy
166,543
+55,634
+50% +$864K ﹤0.01% 3291
2021
Q1
$1.8M Sell
110,909
-98,892
-47% -$1.6M ﹤0.01% 3577
2020
Q4
$4.44M Sell
209,801
-11,524
-5% -$244K ﹤0.01% 2830
2020
Q3
$3.28M Sell
221,325
-45,683
-17% -$677K ﹤0.01% 2859
2020
Q2
$3.93M Buy
267,008
+196,234
+277% +$2.89M ﹤0.01% 2670
2020
Q1
$831K Buy
70,774
+18,911
+36% +$222K ﹤0.01% 3561
2019
Q4
$1.22M Sell
51,863
-12,451
-19% -$293K ﹤0.01% 3669
2019
Q3
$1.19M Sell
64,314
-19,299
-23% -$357K ﹤0.01% 3652
2019
Q2
$1.56M Sell
83,613
-296,793
-78% -$5.52M ﹤0.01% 3497
2019
Q1
$9.3M Sell
380,406
-67,524
-15% -$1.65M ﹤0.01% 1997
2018
Q4
$11.6M Sell
447,930
-6,660
-1% -$173K ﹤0.01% 1750
2018
Q3
$14.4M Buy
454,590
+188,743
+71% +$5.97M ﹤0.01% 1774
2018
Q2
$10.3M Buy
265,847
+205,302
+339% +$7.98M ﹤0.01% 2033
2018
Q1
$1.67M Buy
60,545
+28,095
+87% +$775K ﹤0.01% 3467
2017
Q4
$587K Sell
32,450
-97,924
-75% -$1.77M ﹤0.01% 4183
2017
Q3
$2.11M Buy
130,374
+87,212
+202% +$1.41M ﹤0.01% 3236
2017
Q2
$597K Buy
43,162
+3,583
+9% +$49.6K ﹤0.01% 4010
2017
Q1
$595K Buy
39,579
+17,442
+79% +$262K ﹤0.01% 4034
2016
Q4
$290K Buy
22,137
+10,970
+98% +$144K ﹤0.01% 4402
2016
Q3
$192K Buy
11,167
+1,858
+20% +$31.9K ﹤0.01% 4338
2016
Q2
$168K Sell
9,309
-2,100
-18% -$37.9K ﹤0.01% 4353
2016
Q1
$217K Buy
11,409
+3,555
+45% +$67.6K ﹤0.01% 4232
2015
Q4
$210K Sell
7,854
-13,798
-64% -$369K ﹤0.01% 4271
2015
Q3
$528K Buy
21,652
+14,354
+197% +$350K ﹤0.01% 3799
2015
Q2
$227K Buy
7,298
+5,996
+461% +$187K ﹤0.01% 4415
2015
Q1
$18K Buy
1,302
+122
+10% +$1.69K ﹤0.01% 5215
2014
Q4
$12K Buy
1,180
+8
+0.7% +$81 ﹤0.01% 5330
2014
Q3
$10K Sell
1,172
-311
-21% -$2.65K ﹤0.01% 5400
2014
Q2
$18K Buy
1,483
+1,383
+1,383% +$16.8K ﹤0.01% 5263
2014
Q1
$1K Buy
+100
New +$1K ﹤0.01% 5549